Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Successful treatment of sarcoidosis.

    Ali Y, Perlman E.

    Ann Intern Med. 2004 Jun 1;140(11):W70. No abstract available. Erratum in: Ann Intern Med. 2004 Jul 20;141(2):163. PMID: 15172930 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Infliximab in uveitis treatment.

    Rudometkin N, Mandava N, Deane K, Olson JL.

    Arch Ophthalmol. 2006 Aug;124(8):1211; author reply 1211-2. No abstract available. PMID: 16908832 [PubMed - indexed for MEDLINE]Related articles

    3.

    Treating intraocular inflammatory disease in the 21st century.

    Nussenblatt R.

    Arch Ophthalmol. 2005 Jul;123(7):1000-1. No abstract available. PMID: 16009844 [PubMed - indexed for MEDLINE]Related articles

    4.

    Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.

    Mallbris L, Ljungberg A, Hedblad MA, Larsson P, Ståhle-Bäckdahl M.

    J Am Acad Dermatol. 2003 Feb;48(2):290-3.PMID: 12582407 [PubMed - indexed for MEDLINE]Related articles

    5.

    Favorable response to high-dose infliximab for refractory childhood uveitis.

    Kahn P, Weiss M, Imundo LF, Levy DM.

    Ophthalmology. 2006 May;113(5):860-4.e2. Epub 2006 Mar 20.PMID: 16545455 [PubMed - indexed for MEDLINE]Related articles

    6.

    Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.

    Sweiss NJ, Welsch MJ, Curran JJ, Ellman MH.

    Arthritis Rheum. 2005 Oct 15;53(5):788-91. No abstract available. PMID: 16208666 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [The role of tumor necrosis factor in pathogenesis and treatment of sarcoidosis]

    Vizel' AA, Guryleva ME, Vizel' EA, Nasretdinova GP.

    Klin Med (Mosk). 2003;81(9):4-8. Review. Russian. No abstract available. PMID: 14598582 [PubMed - indexed for MEDLINE]Related articles

    8.

    Treatment of therapy-resistant sarcoidosis with adalimumab.

    Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L, Benticuaga MN.

    Clin Rheumatol. 2006 Jul;25(4):596-7. Epub 2005 Oct 25.PMID: 16247590 [PubMed - indexed for MEDLINE]Related articles

    9.

    Tumor necrosis factor alpha blockade as therapy for sarcoidosis: comment on the article by Ulbricht et al.

    Lee AS, Utz JP, Specks U.

    Arthritis Rheum. 2004 Aug;50(8):2717-8; author reply 2718-9. No abstract available. PMID: 15334498 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Infliximab for chronic cystoid macular edema associated with uveitis.

    Markomichelakis NN, Theodossiadis PG, Pantelia E, Papaefthimiou S, Theodossiadis GP, Sfikakis PP.

    Am J Ophthalmol. 2004 Oct;138(4):648-50.PMID: 15488796 [PubMed - indexed for MEDLINE]Related articles

    11.

    Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

    Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, Feldman BM, Laxer RM, Schneider R, Silverman ED.

    Rheumatology (Oxford). 2006 Aug;45(8):982-9. Epub 2006 Feb 3.PMID: 16461435 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Infliximab therapy for complicated sarcoidosis.

    Cook MC.

    Ann Intern Med. 2002 Aug 20;137(4):296-7; author reply 296-7. No abstract available. PMID: 12186527 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Optimizing the use of tumor necrosis factoralpha inhibitors in refractory uveitis.

    Sebastian RT, Harding SP, Bucknall RC, Pearce IA.

    Arch Ophthalmol. 2006 Oct;124(10):1505; author reply 1505-6. No abstract available. PMID: 17030729 [PubMed - indexed for MEDLINE]Related articles

    14.

    A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

    Suhler EB, Smith JR, Wertheim MS, Lauer AK, Kurz DE, Pickard TD, Rosenbaum JT.

    Arch Ophthalmol. 2005 Jul;123(7):903-12.PMID: 16009830 [PubMed - indexed for MEDLINE]Related articles

    15.

    Adalimumab for treatment of cutaneous sarcoidosis.

    Heffernan MP, Smith DI.

    Arch Dermatol. 2006 Jan;142(1):17-9. No abstract available. PMID: 16415380 [PubMed - indexed for MEDLINE]Related articles

    16.

    Infliximab therapy for complicated sarcoidosis.

    O'Connor TM, Shanahan F, Bredin CP.

    Ann Intern Med. 2002 Aug 20;137(4):296-7; author reply 296-7. No abstract available. PMID: 12186528 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.

    Rosen T, Doherty C.

    Dermatol Online J. 2007 Jul 13;13(3):14.PMID: 18328208 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [Pharmacologic treatment of sarcoidosis]

    Cîlţ C.

    Pneumologia. 2005 Apr-Jun;54(2):66-71. Review. Romanian. PMID: 16536004 [PubMed - indexed for MEDLINE]Related articles

    19.

    Anti-TNF-alpha therapy for sight threatening uveitis.

    Lindstedt EW, Baarsma GS, Kuijpers RW, van Hagen PM.

    Br J Ophthalmol. 2005 May;89(5):533-6.PMID: 15834077 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts.

    Sweiss NJ, Curran J, Baughman RP.

    Clin Dermatol. 2007 May-Jun;25(3):341-6. Review.PMID: 17560312 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data